COX7CP1

Across TCGA pan-cancer cohorts, COX7CP1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of COX7CP1’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where COX7CP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types COX7CP1 is over-expressed in tumor, although a few such as STAD and LUAD show the opposite, repressed pattern.

LIHC, STAD, and CHOL are the cancer types where COX7CP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in COX7CP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Male	All	+0.510	<.001	6	view →
STAD	Male	III,IV	−1.011	.001	4	view →
CHOL	All	All	+0.764	<.001	3	view →
LUAD	All	IV	−1.000	.012	2	view →
KICH	All	III,IV	+0.521	.018	2	view →
KIRP	Female	II,III,IV	+0.473	.038	2	view →
HNSC	All	All	−0.236	.024	2	view →
THCA	Female	II,III,IV	+0.414	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

COX7CP1–LIHC

Open the LIHC breakdown →